MapLight Therapeutics (MPLT) Non-Current Assets (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Non-Current Assets came in at $154.8 million in Q4 2025, up 593.92% year-on-year from $22.3 million in Q4 2024, and up 1199.45% quarter-over-quarter from $11.9 million in Q3 2025.
MapLight Therapeutics (MPLT) Non-Current Assets (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Non-Current Assets across 2 years of filings, most recently posting $154.8 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - | 154.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 154.84 Mn |
| Sep 30, 2025 | 11.92 Mn |
| Dec 31, 2024 | 22.31 Mn |